首页> 外文期刊>Hepato-gastroenterology. >Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute.
【24h】

Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute.

机译:在一家癌症研究所对肝胆胰疾病患者进行肝切除和胰腺切除联合血管切除术。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND/AIMS: In advanced cancers of hepatobiliary and pancreatic lesions, major vascular resection and reconstruction are necessary to accomplish curative resection, which may provide better patient outcomes. METHODOLOGY: Surgical records, morbidity and mortality, and prognosis were examined in patients with combined vascular resection. Thirty-six patients underwent 18 hepatectomies and 18 pancreatectomies. RESULTS: In 18 patients who underwent hepatic resection, the resected vessels were the portal vein (PV) in 10, vena cava or hepatic vein in 9 and right hepatic artery (RHA) in 3. An artificial graft was used in 2 to replace the vena cava. Vascular bypass was performed in 5 patients. Morbidity was due to biliary stricture in 1 patient and adult respiratory distress syndrome in another who died during hospital stay. Fourteen (82%) had cancer recurrence, of whom 12 died of cancer, one died of other disease, and 2 survived cancer-free. The 5-year survival was 28%. In 18 patients who underwent pancreatectomy, resected vessels were PV in 18 and RHA in 1. An artificial graft was used in 3 and vascular passive bypass was performed in 6. One patient died of sepsis after total pancreatectomy during hospital stay. Eleven (64%) had cancer recurrence, of whom 11 died of cancer, 2 died of other disease, and 4 survived cancer-free. The 3-year survival was 27%. CONCLUSIONS: Complete surgical resection (R0) combined with main vascular resection could be safely performed in many patients with disease of the hepatobiliary and pancreas, which achieved longer survival in some patients even in the advanced stage.
机译:背景/目的:在肝胆和胰腺病变的晚期癌症中,必须进行大血管切除和重建才能完成根治性切除,这可能会为患者提供更好的治疗效果。方法:对合并血管切除术的患者的手术记录,发病率,死亡率和预后进行了检查。 36例患者接受了18例肝切除术和18例胰腺切除术。结果:18例行肝切除术的患者中,切除的血管为门静脉(PV)10例,腔静脉或肝静脉9例,右肝动脉(RHA)3例。人工移植2例代替腔静脉5例患者进行了血管搭桥术。发病原因是1例患者因胆道狭窄而另一例在住院期间死亡的成人呼吸窘迫综合征。 14例(82%)的癌症复发,其中12例死于癌症,1例死于其他疾病,2例未患癌症。 5年生存率为28%。在18例行胰腺切除术的患者中,切除的血管18例行PV,1例行RHA。3例行人工移植,6例行血管被动旁路手术。1例患者在住院期间因全胰腺切除术死于败血症。 11例(64%)患有癌症复发,其中11例死于癌症,2例死于其他疾病,4例未患癌症。 3年生存率为27%。结论:许多肝胆胰腺疾病患者可以安全地进行完整的外科切除术(R0)结合主血管切除术,即使在晚期也可以使更长的生存期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号